Effects of angiotensin II receptor blockade on cerebral, cardiovascular, counter-regulatory, and symptomatic responses during hypoglycaemia in patients with type 1 diabetes

Conclusion:
In conclusion candesartan has no effect on cerebral function during mild experimental hypoglycaemia in subjects with type 1 diabetes and high RAS activity. Candesartan may reduce glucose utilisation or increase endogenous glucose production during hypoglycaemia.

Source: Journal of the Renin-Angiotensin-Aldosterone System : JRAAS - December 23, 2015 Category: Biomedical Science Authors: Faerch, L. H., Thorsteinsson, B., Tarnow, L., Holst, J. J., Kjaer, T., Kanters, J., Larroude, C., Dela, F., Pedersen-Bjergaard, U. Tags: Original Articles Source Type: research